Stock Earnings

Question 1

What are Edwards Lifesciences Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Edwards Lifesciences Corp has a total asset of $13,696, Net profit of $1,073

Question 2

What are the key financial ratios for EW?

Accepted Answer

Edwards Lifesciences Corp's Current ratio is 4.07, has a Net margin is 17.68, sales per share of $10.35.

Question 3

How is Edwards Lifesciences Corp's revenue broken down by segment or geography?

Accepted Answer

Edwards Lifesciences Corp largest revenue segment is Transcatheter Aortic Valve Replacement, at a revenue of 4,487,700,000 in the most earnings release.For geography, United States is the primary market for Edwards Lifesciences Corp, at a revenue of 3,543,100,000.

Question 4

Is Edwards Lifesciences Corp profitable?

Accepted Answer

yes, according to the latest financial statements, Edwards Lifesciences Corp has a net profit of $1,073

Question 5

Does Edwards Lifesciences Corp have any liabilities?

Accepted Answer

yes, Edwards Lifesciences Corp has liability of 3,359

Question 6

How many outstanding shares for Edwards Lifesciences Corp?

Accepted Answer

Edwards Lifesciences Corp has a total outstanding shares of 580.7

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	6,303	6,067	5,439	5,010	4,464	5,232
Revenue Growth (YoY)	14%	12%	9%	12%	-15%	19%
Cost of Revenue	1,395	1,334	1,117	978	723	1,248
Gross Profit	4,908	4,733	4,322	4,031	3,740	3,983
Selling, General & Admin	2,141	2,085	1,789	1,582	1,357	1,493
Research & Development	1,087	1,079	1,053	962	843	903
Operating Expenses	3,154	3,084	2,841	2,519	2,165	2,272
Other Non Operating Income (Expenses)	76	3	7	4	1	1
Pretax Income	1,298	1,272	1,548	1,372	1,519	1,702
Income Tax Expense	224	216	152	152	195	198
Net Income	1,096	1,073	4,174	1,402	1,521	1,503
Net Income Growth	-74%	-74%	198%	-8%	1%	83%
Shares Outstanding (Diluted)	580.7	585.8	599.3	609.4	624.2	631.2
Shares Change (YoY)	-1%	-2%	-2%	-2%	-1%	0%
EPS (Diluted)	1.88	1.83	6.96	2.3	2.43	2.38
EPS Growth	-74%	-74%	202.99%	-5%	2%	83%
Free Cash Flow	1,089	1,335	259	629	953	1,402
Free Cash Flow Per Share	1.87	2.27	0.43	1.03	1.52	2.22
Gross Margin	77.86%	78.01%	79.46%	80.45%	83.78%	76.12%
Operating Margin	27.81%	27.16%	27.21%	30.17%	35.25%	32.68%
Profit Margin	17.38%	17.68%	76.74%	27.98%	34.07%	28.72%
Free Cash Flow Margin	17.27%	22%	4.76%	12.55%	21.34%	26.79%
EBITDA	1,913	1,804	1,635	1,656	1,713	1,844
EBITDA Margin	30.35%	29.73%	30.06%	33.05%	38.37%	35.24%
D&A For EBITDA	160	156	155	144	139	134
EBIT	1,753	1,648	1,480	1,512	1,574	1,710
EBIT Margin	27.81%	27.16%	27.21%	30.17%	35.25%	32.68%
Effective Tax Rate	17.25%	16.98%	9.81%	11.07%	12.83%	11.63%

Edwards Lifesciences Corp (EW) Price

EW Stock Price Chart

EW Income

Follow-Up Questions